We are live on
!
Find out more
Wealth Enhancement Advisory Services Portfolio holdings
AUM
$59.8B
1-Year Est. Return
29.42%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
+29.42%
3 Year Est. Return
+77.06%
5 Year Est. Return
+66.38%
10 Year Est. Return
+178.95%
AUM
$60.5B
AUM Growth
+$8.17B
(+16%)
Cap. Flow
+$3.47B
Cap. Flow
% of AUM
5.74%
Top 10 Holdings %
Top 10 Hldgs %
23.65%
Holding
3,520
New
510
Increased
1,636
Reduced
1,103
Closed
162
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JMTG
JPMorgan Mortgage-Backed Securities ETF
JMTG
|
+$141M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$128M |
| 3 |
ALPS Smith Core Plus Bond ETF
SMTH
|
+$125M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$117M |
| 5 |
Apple
AAPL
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$131M |
| 2 |
JPMorgan Short Duration Core Plus ETF
JSCP
|
+$77.9M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$62.1M |
| 4 |
UnitedHealth
UNH
|
+$35.8M |
| 5 |
CBRE Group
CBRE
|
+$32.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.75% |
| 2 | Financials | 6.58% |
| 3 | Industrials | 4.51% |
| 4 | Consumer Discretionary | 3.84% |
| 5 | Healthcare | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Galectin Therapeutics
GALT
$348M
| $77.4K | ﹤0.01% |
35,520
-621
| -2% | -$929 |
|
3177
Resources Connection
RGP
$145M
| $77.3K | ﹤0.01% |
12,825
+222
| +2% | +$1.21K |
|
|
DEFT
3178
Defi Technologies
DEFT
$183M
| $75.9K | ﹤0.01% |
+24,183
| New | +$81K |
|
|
CMRC
3179
Commerce.com Inc Series 1
CMRC
$184M
| $75.7K | ﹤0.01% |
+14,761
| New | +$76K |
|
3180
8x8 Inc
EGHT
$332M
| $75.3K | ﹤0.01% |
34,880
+11,022
| +46% | +$19.5K |
|
3181
FuboTV Inc
FUBO
$273M
| $74.9K | ﹤0.01% |
1,691
-108
| -6% | -$4.04K |
|
3182
Sigma Lithium
SGML
$1.28B
| $74.3K | ﹤0.01% |
14,325
-60,100
| -81% | -$397K |
|
3183
ProPetro Holding
PUMP
$1.35B
| $74K | ﹤0.01% |
+11,725
| New | +$67.1K |
|
3184
Novavax
NVAX
$1.31B
| $72.7K | ﹤0.01% |
+10,695
| New | +$70.8K |
|
3185
Navitas Semiconductor
NVTS
$3.63B
| $70.2K | ﹤0.01% |
+10,896
| New | +$42K |
|
3186
James River Group Holdings
JRVR
$217M
| $70K | ﹤0.01% |
12,420
-2,815
| -18% | -$14.3K |
|
|
DAWN
3187
DELISTED
Day One Biopharmaceuticals
DAWN
| $69.8K | ﹤0.01% |
10,262
-892
| -8% | -$6.14K |
|
|
AEF
3188
abrdn Emerging Markets Equity Income Fund
AEF
$367M
| $69.4K | ﹤0.01% |
11,543
+158
| +1% | +$839 |
|
3189
SelectQuote
SLQT
$121M
| $69.3K | ﹤0.01% |
+28,632
| New | +$75.2K |
|
3190
RPC Inc
RES
$1.3B
| $69.3K | ﹤0.01% |
+13,374
| New | +$64.4K |
|
3191
Clarivate
CLVT
$1.16B
| $68.5K | ﹤0.01% |
15,613
-10,683
| -41% | -$43K |
|
|
EWCZ
3192
DELISTED
European Wax Center
EWCZ
| $68K | ﹤0.01% |
+11,729
| New | +$53.3K |
|
3193
B&G Foods
BGS
$286M
| $67.6K | ﹤0.01% |
+14,993
| New | +$78.3K |
|
3194
Lexicon Pharmaceuticals
LXRX
$1.1B
| $67.1K | ﹤0.01% |
74,454
+5,247
| +8% | +$3.4K |
|
|
DENN
3195
DELISTED
Denny's
DENN
| $67K | ﹤0.01% |
+14,812
| New | +$56.8K |
|
3196
MannKind Corp
MNKD
$1.32B
| $65.5K | ﹤0.01% |
18,205
-1,368
| -7% | -$6.03K |
|
3197
PUT
Celestica
CLS
$36.5B
| $64.8K | ﹤0.01% |
+13,000
| New | +$1.38M |
|
3198
Nuvation Bio
NUVB
$2.32B
| $64.6K | ﹤0.01% |
+30,919
| New | +$64.4K |
|
|
MRCC
3199
DELISTED
Monroe Capital Corp
MRCC
| $64.6K | ﹤0.01% |
10,000
-821
| -8% | -$5.5K |
|
3200
SmartRent
SMRT
$272M
| $63.5K | ﹤0.01% |
57,179
+22,582
| +65% | +$20.2K |
|
Similar funds
QCM
NAMI
Wealth Enhancement Advisory Services's Q2 2025 Portfolio in Review
As of Q2 2025, Wealth Enhancement Advisory Services held 3,520 positions worth $60.5B, up 16% from $52.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Wealth Enhancement Advisory Services deployed $3.47B of net new capital in Q2 2025, opening 510 new positions and adding to 1,636 existing holdings. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 2,815,302 shares worth $141M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Palantir, an estimated $131M trimmed.
- Wealth Enhancement Advisory Services's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 2,815,302 shares worth $141M.
- Wealth Enhancement Advisory Services added most to iShares Core US Aggregate Bond ETF in Q2 2025, an estimated $128M increase.
- Wealth Enhancement Advisory Services's biggest Q2 2025 reduction was Palantir, cutting an estimated $131M.
- Wealth Enhancement Advisory Services fully exited Discover Financial Services in Q2 2025, selling an estimated $10.8M.
- Wealth Enhancement Advisory Services's ten largest holdings make up 24% of its $60.5B portfolio in Q2 2025.
- Wealth Enhancement Advisory Services opened 510 new positions and closed 162 in Q2 2025.
- Wealth Enhancement Advisory Services's portfolio value rose 16% quarter-over-quarter to $60.5B.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2025, filed 10 Jul 2025.